Literature DB >> 12725790

The use of HPLC-MS in T-cell epitope identification.

Claudia Lemmel1, Stefan Stevanović.   

Abstract

The hunt for T-cell epitopes is going on because hopes are set on such peptide sequences for diagnosis and vaccine development in the fight against infectious and tumor diseases. In addition to a variety of other techniques used in T-cell epitope identification, mass spectrometers coupled to microcapillary liquid chromatography have now become an important and sensitive tool in separation, detection, and sequence analysis of highly complex natural major histocompatibility complex (MHC) ligand mixtures. In this article, we review the basics of mass spectrometric techniques and their on-line coupling to microcapillary liquid chromatography (microcap-LC). Furthermore, we introduce current strategies for the identification of new T-cell epitopes using microcapillary liquid chromatography-mass spectrometry (microcap-LC-MS).

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12725790     DOI: 10.1016/s1046-2023(02)00347-x

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  3 in total

Review 1.  The sentinel within: exploiting the immune system for cancer biomarkers.

Authors:  Karen S Anderson; Joshua LaBaer
Journal:  J Proteome Res       Date:  2005 Jul-Aug       Impact factor: 4.466

2.  A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens.

Authors:  Michael D Valentino; C Siddiq Abdul-Alim; Zachary J Maben; Denise Skrombolas; Lucinda L Hensley; Thomas H Kawula; Michelle Dziejman; Edith M Lord; Jeffrey A Frelinger; John G Frelinger
Journal:  J Immunol Methods       Date:  2011-08-18       Impact factor: 2.303

3.  Identification of T-cell epitopes in Francisella tularensis using an ordered protein array of serological targets.

Authors:  Michael D Valentino; Zachary J Maben; Lucinda L Hensley; Matthew D Woolard; Thomas H Kawula; Jeffrey A Frelinger; John G Frelinger
Journal:  Immunology       Date:  2011-01-07       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.